title: End-of-life research: do we need to build proxy consent into all clinical trial protocols studying the terminal phase?
authors.forename: Caitlin
authors.initials: C
authors.lastname: Sheehan
authors.forename: Meera
authors.initials: M
authors.lastname: Agar
authors.forename: David C
authors.initials: DC
authors.lastname: Currow
mesh_terms: D002986:Clinical Trials as Topic / Q000592:standards*; D006801:Humans; D007258:Informed Consent / Q000592:standards*; D019727:Proxy; D019452:Terminally Ill